Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-015-6 | CAS number: 505-65-7
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Unfortunately no data is available regarding skin sensitization of 1,3-dioxepane. But data for other cyclic acetals consistently show that no indication for a skin sensitizing potential exists.
1,3,5-trioxane (CasNo. 110-88-3) proofed not to be sensitizing in a guinea pig maximization test (BASF AG, 1989). The study was performed according to the OECD guideline 406 and GLP.
In a supporting guinea pig study 1,3,5-trioxane was tested together with 1,3-dioxolane (CasNo. 646-06-0) and the cyclic tetramer of ethylene oxide (2,4,6,8-Tetraoxanonane, CasNo. 13353-03-2) (Rao, 1981). The assay was performed according to a guinea pig maximization assay (4 inductions, 1 indradermal application of adjuvance, 1 challenge), though reporting of the test results is not very detailed. For all 3 tested acetals no indication for a skin sensitizing potential was identified.
For 1,3-dioxolane additional data of low/undefined quality exists (not included in IUCLID/CSR). In a modified guinea pig assay according to Magnusson and Kligman no dermatitis related to oversensitivity was identified (Czajkowska et al. (1987), Experimental studies of toxic effects of 1,3,5-trioxane and 1,3-dioxolane. I Acute toxic effect. Medycyna Pracy 38: 184-190).
The data-base for evaluation can even be extended to 1,4-dioxane (CasNo. 123-91-1), a cyclic 6-ring with 2 oxygen atoms. Likewise no indication for a skin sensitizing potential was identified in a OECD guideline 406 maximization assay in guinea pigs (BASF AG, 1993; data not shown).
Summarized, a reliable cross reading to a variety of cylic acetalic and non acetalic molecules with 2-4 ring-oxygen atoms can be performed. All sensitization data unambigously shows that no concern for a skin sensitizing potential can be derived for 1,3-dioxepane. By weight of evidence and with respect of animal welfare the performance of an in vivo skin sensitization assay is not indicated.
Nevertheless, similar to 1,3,5-trioxane, 1,3-dioxepane degradation can result in the release of small amounts of formaldehyde (BASF AG, 1998), though to a way smaller extend. In order to protect formaldehyde-susceptible individuals, this observation should be indicated in the hazard communication (MSDS).
Migrated from Short description of key information:
A reliable cross-reading to other cyclic acetals consistently indicates no senitizing potential.
Respiratory sensitisation
Endpoint conclusion
- Additional information:
- Migrated from Short description of key information:
No data available
Justification for classification or non-classification
In a variety of structurally similar substances no indications for a skin sensitizing potential were identified. Therefore no classification for skin-sensitization is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
